Figures (7)  Tables (1)
    • Figure 1. 

      Changes in appearance during whey protein glycation, including control (CON), glucose (GLU), methylglyoxal (MGO) and glyoxal (GO) group.

    • Figure 2. 

      Fluorescence emission spectroscopy of whey protein after glycation, representing (a) control, (b) glucose, (c) methylglyoxal (MGO) and (d) glyoxal (GO) group at 120 min of glycation processing respectively.

    • Figure 3. 

      Changes in amino group releasing glycated whey protein after in vitro gastrointestinal digestion. Letters I−III denote significance levels (p < 0.05) between different treatment groups after the same digestion time, including control (CON), glucose (GLU), methylglyoxal (MGO) and glyoxal (GO) group.

    • Figure 4. 

      FPLC profiles for gastrointestinal digests from control or glycated whey protein, including control (CON), glucose (GLU), methylglyoxal (MGO) and glyoxal (GO) group.

    • Figure 5. 

      Influence of different concentration of whey protein digests treatment on STC-1 cells viability, which was tested by (a) Alamar blue and (b) CCK-8.

    • Figure 6. 

      The quantity of (a) GLP-1, (b) CCK, (c) GIP, (d) PYY secreted by STC-1 cells after glycated whey protein gastrointestinal digests treatment. Letters I−II denote significance levels (p < 0.05) between treatment groups after gastrointestinal digestion, including control (CON), glucose (GLU), methylglyoxal (MGO) and glyoxal (GO) group.

    • Figure 7. 

      GLP-1 and CCK mRNA levels in STC-1 cells after (a) glycated whey protein gastric and (b) intestinal digests treatment. Letters I and II denote significance levels (p < 0.05) between different treatment groups for the same hormones mRNA secreted after gastric and gastrointestinal digestion, including control (CON), glucose (GLU), methylglyoxal (MGO) and glyoxal (GO) group.

    • SampleUV absorbance
      0 min15 min60 min120 min
      CON0.29 ± 0.01c,B0.33 ± 0.01b,A0.35 ± 0.01b,A0.34 ± 0.02a,A
      GLU0.38 ± 0.01a,B0.42 ± 0.01a,A0.42 ± 0.02a,A0.37 ± 0.01a,B
      MGO0.32 ± 0.01b,B0.32 ± 0.01b,B0.34 ± 0.01b,A0.31 ± 0.01b,B
      GO0.28 ± 0.01c,A0.22 ± 0.01c,B0.13 ± 0.00c,C0.13 ± 0.00c,C

      Table 1. 

      Changes in free amino acids during whey protein glycation, including control (CON), glucose (GLU), methylglyoxal (MGO) and glyoxal (GO) group.